(Q38522810)

3 September 2017

0 references

1 reference

title

Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis (English)

1 reference

3 September 2017

1 reference

1 reference

5

1 reference

3 September 2017

Graeme Meintjes

6

0 references

author name string

Phiona E Namale

1

1 reference

3 September 2017

Leila H Abdullahi

2

1 reference

3 September 2017

Stacey Fine

3

1 reference

3 September 2017

Monika Kamkuemah

4

1 reference

3 September 2017

publication date

1 June 2015

1 reference

3 September 2017

number of pages

23

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

3 September 2017

volume

10

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

1077-1099

1 reference

Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients

3 September 2017

cites work

1 reference

The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Immune restoration disease after antiretroviral therapy

21 January 2018

1 reference

Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

21 January 2018

1 reference

Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis

21 January 2018

1 reference

Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction

21 January 2018

1 reference

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

21 January 2018

1 reference

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial

21 January 2018

1 reference

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

21 January 2018

1 reference

Integration of antiretroviral therapy with tuberculosis treatment

21 January 2018

1 reference

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

21 January 2018

1 reference

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

21 January 2018

1 reference

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

21 January 2018

1 reference

Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis

21 January 2018

1 reference

Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs

21 January 2018

1 reference

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

21 January 2018

1 reference

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

21 January 2018

1 reference

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand

21 January 2018

1 reference

Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings

21 January 2018

1 reference

Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients

21 January 2018

1 reference

Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART.

21 January 2018

1 reference

Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique

21 January 2018

1 reference

Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study

21 January 2018

1 reference

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation

21 January 2018

1 reference

Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa

21 January 2018

1 reference

Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India

21 January 2018

1 reference

Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand

21 January 2018

1 reference

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection

21 January 2018

1 reference

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

21 January 2018

1 reference

Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis

21 January 2018

1 reference

Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome

21 January 2018

1 reference

Timing of initiation of antiretroviral drugs during tuberculosis therapy

21 January 2018

1 reference

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis

21 January 2018

1 reference

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania

21 January 2018

1 reference

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis.

21 January 2018

1 reference

Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with Mycobacterium tuberculosis.

21 January 2018

1 reference

Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis.

21 January 2018

1 reference

Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease

21 January 2018

1 reference

Management of the immune reconstitution inflammatory syndrome.

21 January 2018

1 reference

Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.15.9

1 reference

3 September 2017

1 reference